GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids

Y. Izuhara, H. Matsumoto, Y. Kanemitsu, K. Izuhara, Y. Tohda, T. Horiguchi, H. Kita, K. Kuwabara, T. Keisuke, K. Otsuka, M. Fujimura, N. Okura, K. Tomita, A. Yokoyama, H. Onishi, Y. Nakano, T. Oguma, S. Hozawa, T. Nagasaki, I. Ito, T. Oguma, H. Inoue, T. Tajiri, T. Iwata, J. Ono, S. Ohta, M. Tamari, T. Hirota, T. Yokoyama, A. Niimi, M. Mishima (Kyoto, Saga, Aichi, Osaka, Hyogo, Kanazawa, Kochi, Shiga, Hiroshima, Kanagawa, Yokohama, Saitama, Japan)

Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Session: Genetics and environmental factors underlying asthma and COPD
Session type: Poster Discussion
Number: 4777
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Y. Izuhara, H. Matsumoto, Y. Kanemitsu, K. Izuhara, Y. Tohda, T. Horiguchi, H. Kita, K. Kuwabara, T. Keisuke, K. Otsuka, M. Fujimura, N. Okura, K. Tomita, A. Yokoyama, H. Onishi, Y. Nakano, T. Oguma, S. Hozawa, T. Nagasaki, I. Ito, T. Oguma, H. Inoue, T. Tajiri, T. Iwata, J. Ono, S. Ohta, M. Tamari, T. Hirota, T. Yokoyama, A. Niimi, M. Mishima (Kyoto, Saga, Aichi, Osaka, Hyogo, Kanazawa, Kochi, Shiga, Hiroshima, Kanagawa, Yokohama, Saitama, Japan). GLCCI1 variant accelerates pulmonary function decline in patients with asthma receiving inhaled corticosteroids. Eur Respir J 2014; 44: Suppl. 58, 4777

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Expression of genes associated with neurogenic inflammation in pediatric asthma
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013


Effect of TRPV4 gene polymorphisms on osmotic airway hyperresponsiveness in patients with asthma
Source: International Congress 2015 – Genetics and environmental factors in phenotypes of asthma and COPD
Year: 2015


Effect of ADRB2 gene polymorphism on treatment outcomes in asthmatics: Cold airway hyperresponsiveness and asthma control
Source: International Congress 2014 – Genetics and environmental factors underlying asthma and COPD
Year: 2014


Autoreactivity in patients with combined COPD and asthma phenotype
Source: International Congress 2014 – Novel approaches to human studies in allergy and asthma
Year: 2014


Characteristics of the adult corticosteroid-dependent severe asthma in UBIOPRED consortium
Source: International Congress 2014 – Novel targets and drugs for asthma and COPD
Year: 2014

Sputum cell mRNA transcripts demonstrate alteration of endothelin metabolism in severe asthma and COPD
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

The impact of stepwise withdrawal of inhaled corticosteroids on lung function in COPD patients receiving dual bronchodilation: WISDOM study
Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments
Year: 2014


TRPM8 gene polymorphisms and their relation to cold airway hyperresponsiveness in patients with bronchial asthma
Source: Annual Congress 2013 –Translational research to bridge the need within clinical decision making
Year: 2013


Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Interaction between the Arg16 homozygous genotype, inhaled corticosteroids and long acting beta agonists for asthma exacerbations in children? Leukotriene receptor antagonists to the rescue?
Source: Annual Congress 2013 –Asthma and lung development: from genes to environment
Year: 2013

Study on sputum differential counts in asthmatics controlled & uncontrolled on inhaled corticosteroids
Source: International Congress 2015 – Non-exhaled biomarkers in the assessment of airways disease
Year: 2015


A pilot study for markers which can reflect asthmatic activity before and after reduction of inhaled corticosteroids
Source: Annual Congress 2013 –Assessment of airway inflammation by exhaled gases
Year: 2013

Effect of roflumilast on airway remodeling in a murine model of chronic asthma
Source: International Congress 2015 – New models for treating airway diseases
Year: 2015


Pulmonary response to salbutamol inhalation using dynamic OE-MRI in patients with asthma
Source: Annual Congress 2013 –The different modalities for current imaging and for future issues
Year: 2013


Mast cell gene signature enrichment associates with late-onset severe asthma
Source: International Congress 2016 – Phenotyping asthma
Year: 2016


Combination therapy of ICSs/LABAs plus montelucastin patients with severe asthma
Source: International Congress 2015 – Therapeutic approaches in inflammatory lung disease
Year: 2015

Role of TRPV1 and TRPV2 gene polymorphisms in the development of airway hyperresponsiveness to osmotic stimuli in patients with asthma
Source: International Congress 2016 – Role of genetics and exposures in COPD and asthma
Year: 2016


Re-sequencing of IL33 and IL1RL1 in severe asthma patients identifies novel variation
Source: International Congress 2014 – Genes and environment in asthma and COPD
Year: 2014

Wet cough in paediatric severe therapy resistant asthma (STRA)
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016